ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,479Medicare Part D Prescriptions Filled, Including Refills

Rank: 1141 out of 3647

$669K Total Retail Price of All Prescriptions

Rank: 621 out of 3647

618 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 618 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,871 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 400 377 1 1
LISINOPRIL 346 326 2 4
CRESTOR 323 304 3 19
OMEPRAZOLE 315 285 4 3
METOPROLOL TARTRATE 245 231 5 7
AMLODIPINE BESYLATE 238 216 6 2
HYDROCHLOROTHIAZIDE 217 211 7 9
LOSARTAN POTASSIUM 181 169 8 11
ATENOLOL 180 178 9 10
METFORMIN HCL 171 160 10 6
ATORVASTATIN CALCIUM 171 166 10 13
LEVOTHYROXINE SODIUM 163 150 12 5
ZOLPIDEM TARTRATE 139 133 13 14
SYNTHROID 136 134 14 42
DIOVAN 132 131 15 40
METOPROLOL SUCCINATE 127 113 16 18
ALENDRONATE SODIUM 115 115 17 23
ALPRAZOLAM 110 109 18 31
CLOPIDOGREL 106 76 19 26
PLAVIX 104 96 20 39
TAMSULOSIN HCL 100 78 21 28
CARVEDILOL 93 78 22 20
FLUTICASONE PROPIONATE 92 87 23 32
LOSARTAN-HYDROCHLOROTHIAZIDE 88 88 24 48
VIAGRA 85 78 25 69
NAPROXEN 81 74 26 70
GABAPENTIN 71 54 27 17
ENALAPRIL MALEATE 70 70 28 35
AZITHROMYCIN 67 61 29 34
LOVASTATIN 67 67 29 21
JANUVIA 65 65 31 72
FUROSEMIDE 64 57 32 8
LANTUS SOLOSTAR 64 54 32 124
NEXIUM 64 59 32 44
PANTOPRAZOLE SODIUM 63 62 35 38
DIOVAN HCT 61 57 36 80
TEMAZEPAM 61 61 36 47
PAROXETINE HCL 58 58 38 60
LOVAZA 56 48 39 117
FAMOTIDINE 53 53 40 61
ALLOPURINOL 53 46 40 37
DONEPEZIL HCL 53 53 40 30
GLIMEPIRIDE 52 52 43 45
LANSOPRAZOLE 51 37 44 116
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 44 74
WARFARIN SODIUM 51 51 44 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.